Page last updated: 2024-10-31

midazolam and Glucose Intolerance

midazolam has been researched along with Glucose Intolerance in 1 studies

Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.

Glucose Intolerance: A pathological state in which BLOOD GLUCOSE level is less than approximately 140 mg/100 ml of PLASMA at fasting, and above approximately 200 mg/100 ml plasma at 30-, 60-, or 90-minute during a GLUCOSE TOLERANCE TEST. This condition is seen frequently in DIABETES MELLITUS, but also occurs with other diseases and MALNUTRITION.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Windeløv, JA1
Pedersen, J1
Holst, JJ1

Other Studies

1 other study available for midazolam and Glucose Intolerance

ArticleYear
Use of anesthesia dramatically alters the oral glucose tolerance and insulin secretion in C57Bl/6 mice.
    Physiological reports, 2016, Volume: 4, Issue:11

    Topics: Anesthetics; Animals; Blood Glucose; Butyrophenones; Drug Combinations; Female; Fentanyl; Glucose In

2016